How Big Pharma Rigged the Patent System

How Big Pharma Rigged the Patent System - The American Prospect

Drug patents are supposed to expire in 20 years. Thanks to legal trickery, though, it usually takes a lot longer than that.

Big Pharma's Patent Abuses Are Fueling Drug Pricing Crisis | TIME

1 in 4 Americans cannot afford to take their medications because of Big Pharma's drug patent abuses, write Tahir Amin and David Mitchell.

A Legal Analysis of Big Pharma's Evasion and Weaponization of ...

Pharmaceutical companies have found ways to weaponize United States' patent law and FDA policies. This manipulation of copyright law undermines its ...

Getting the Facts: Drug Companies Increasingly Using Patent… - AHIP

A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching ...

Big Pharma is abusing patents, and it's hurting Americans (opinion)

The American patent system has, since our nation's founding, served as a cornerstone of innovation. But the pharmaceutical industry's ...

Patents Against People: How Drug Companies Price Patients out of ...

... big pharma” is already the gatekeeper for life-saving medicines. The Global South is the next frontier in the patent war, where public health advocates form ...

Pharmaceutical Patent Abuse: To Infinity and Beyond!

The top 12 brand drugs on the market last year are protected by a total of 848 patents (71 per drug) providing an average of 38 years without generic ...

In the case of brand name drugs versus generics, patents can be ...

Pharmaceutical companies use patent thickets — multiple patents covering the same drug — to manipulate the patent system in order to maintain an ...

'Gaming' of U.S. patent system is keeping drug prices sky high ...

Pharmaceutical companies can extend their drug patents, keeping generics off the market, in a process known as "evergreening.

ICYMI: Senate Judiciary Committee Got It Right on Big Pharma's ...

Members of the Committee rightly diagnosed the root cause of out-of-control prescription drug prices in the country: Big Pharma's patent abuse.

Tahir Amin on LinkedIn: How Big Pharma Rigged the Patent System

This article, from Ryan Cooper at The American Prospect, is a comprehensive overview of drug patent abuse and its place at the heart of the ...

Ending the Cesspool in Pharmaceuticals by Taking Away Patent ...

Patent monopolies and related protections allow pharmaceutical companies to sell drugs at prices that are typically several thousand percent above their free ...

Pharma Companies' Challenge to Inflation Reduction Act Heats Up

The Inflation Reduction Act (IRA) compels drug manufacturers to provide Medicare with “access” to their leading medicines at steep discounts.

Arrington Leads Bipartisan Effort to Address Patent Thickets and ...

The newly introduced bill would curb the practice of patent thicketing, bringing much-needed competition to the domestic biosimilars market.

Corruption in Drug Patents: Take Away the Money

As the editorial notes, the worst patent abuses occur with prescription drugs. Drug companies routinely garner dozens of dubious patents for ...

FACT SHEET: BIG PHARMA'S PATENT ABUSE COSTS AMERICAN ...

The pharmaceutical industry's egregious abuse of the patent system is a root cause of high prescription drug prices because it enables Big ...

High drug prices caused by US patent system, not 'foreign freeloaders'

The patent system allows prescription drug companies to hold unfair monopolies, promoting reckless pricing according to Tahir Amin.

Probe Shows Big Pharma 'Manipulated' Patent System and 'Raised ...

"The result of the House Oversight Committee investigation is clear: American families are suffering from outrageous drug prices, while Big ...

Game of Patents - - National Nurses United

... drugs. Page 4. Page 5. 1. Game of Patents: How the US Government and Big Pharma Protect Pharmaceutical Profits by. Working Around Patent Policy.

Big Pharma's GOP firewall is weakening - Axios

Congressional Republicans are increasingly open to cracking down on the tactics pharmaceutical companies use to keep competition at bay.